NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ArkeaBio

ArkeaBio

Private
Boston, MassachusettsEnergy & Sustainabilityhttps://www.arkeabio.com/

Last Round

Series A

Extension

Sep 23, 2025

Total Funding Raised

$45.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ArkeaBio is an agricultural biotechnology company developing a vaccine to reduce methane emissions from ruminant animals.

Sector

Energy & Sustainability

Verticals

Biotechnology, Carbon Capture

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

methane vaccinelivestock methaneagricultural biotechnologymethane reductioncarbon creditsclimate techruminant methanemethane mitigationagtechscope 3 emissionsbiopharmaceuticalsustainability reportingmethanogenic archaea

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ArkeaBio Comparables

Compare ArkeaBio with similar companies based on industry and business-model similarity.

ArkeaBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pasture Biosciences
91%
Lucidome Bio
88%
Blue Ocean Barns
78%

ArkeaBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 23, 2025
Series AMay 8, 2024
SeedDec 12, 2022

Key People

Founding team and executive leadership

Colin South

CEO

Executive Team

Frank Wooten

CEO

Executive Team

ArkeaBio Investors

Notable investors and investment history

ArkeaBio investors
InvestorRounds
Overview CapitalSeries A
Breakthrough Energy VenturesSeries A Extension, Seed, Series A
The Grantham Foundation for the Protection of the EnvironmentSeries A
Lowercarbon CapitalSeries A
Rabo VenturesSeries A
AgriZeroNZSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2025

    Developing a vaccine to reduce methane emissions from livestock.

  • Aug 28, 2025

    Dr. Zach Serber appointed as Chief Technology Officer.

ArkeaBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ArkeaBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ArkeaBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range36
Year Founded2022
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.